Logo - springer
Slogan - springer

Birkhäuser - Birkhäuser BioSciences | Erythropoietins, Erythropoietic Factors, and Erythropoiesis - Molecular, Cellular, Preclinical,

Erythropoietins, Erythropoietic Factors, and Erythropoiesis

Molecular, Cellular, Preclinical, and Clinical Biology

Elliott, Steven G., Foote, MaryAnn, Molineux, Graham (Eds.)

2nd, revised and extended ed. 2009, XVIII, 330 p.

A product of Birkhäuser Basel
Available Formats:
eBook
Information

Springer eBooks may be purchased by end-customers only and are sold without copy protection (DRM free). Instead, all eBooks include personalized watermarks. This means you can read the Springer eBooks across numerous devices such as Laptops, eReaders, and tablets.

You can pay for Springer eBooks with Visa, Mastercard, American Express or Paypal.

After the purchase you can directly download the eBook file or read it online in our Springer eBook Reader. Furthermore your eBook will be stored in your MySpringer account. So you can always re-download your eBooks.

 
$239.00

(net) price for USA

ISBN 978-3-7643-8698-6

digitally watermarked, no DRM

Included Format: PDF

download immediately after purchase


learn more about Springer eBooks

add to marked items

Hardcover
Information

Hardcover version

You can pay for Springer Books with Visa, Mastercard, American Express or Paypal.

Standard shipping is free of charge for individual customers.

 
$299.00

(net) price for USA

ISBN 978-3-7643-8694-8

free shipping for individuals worldwide

online orders shipping within 2-3 days.


add to marked items

  • Covers background, basic science and erythropoiesis-stimulating agents
  • Chapters on the erythropoietin receptor as well as clinical uses of recombinant erythropoietins
  • Also of interest to clinicians in sports medicine
  • International authorship

This second edition is a one-source guide to current information about red blood cell physiology and the action of native and recombinant human erythropoietic factors. Topics in the fields of erythropoiesis, recombinant protein discovery and production, and treatment of patients with anemia due to renal failure, cancer, or chronic diseases are covered. The newest theories in erythropoiesis (receptors, signaling), manufacturing, new formulations, and clinical research are discussed.

 This book is of interest to researchers and clinical investigators in academia and biotechnology and pharmaceutical companies, to clinical research associates, clinical monitors, and physician investigators.

Content Level » Research

Keywords » Activation - anemia - biology - biotechnology - blood cell - cancer - cell - cell physiology - erythropoietin - metabolism - pharmacokinetics - physiology - regulation - research - signal transduction

Related subjects » Birkhäuser BioSciences

Table of contents 

Background.- Erythropoiesis: an overview.- Regulation of endogenous erythropoietin production.- Biology of erythropoietin.- Erythropoiesis—genetic abnormalities.- Erythropoiesis-stimulating agents.- Studies of erythropoiesis and the discovery and cloning of recombinant human erythropoietin.- Commercial production of recombinant erythropoietins.- Biosimilar epoetins.- New molecules and formulations.- Erythropoietin receptor.- Structural basis for the signal transduction of erythropoietin.- Intracellular signaling by the erythropoietin receptor.- Mechanism of erythropoietin receptor activation.- Clinical utility.- Pharmacokinetics of erythropoiesis-stimulating agents.- Use of erythropoietic stimulating agents in the setting of renal disease.- Abuse of recombinant erythropoietins and blood products by athletes.- Role and regulation of iron metabolism in erythropoiesis and disease.- Nonhematopoietic effects of erythropoiesis-stimulating agents.

Popular Content within this publication 

 

Articles

Read this Book on Springerlink

Services for this book

New Book Alert

Get alerted on new Springer publications in the subject area of Pharmacology / Toxicology.